Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections
This study has been completed.
Study NCT00027248   Information provided by MIGENIX Inc.
First Received: November 29, 2001   Last Updated: September 12, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
Bacteremia
Fungemia
More general conditions related to this trial
Bacterial Infections
Infection
Inflammation
Mycoses
Pathologic Processes
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
MBI 226
Sponsors listed in this trial
MIGENIX Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services